Current Price Status
Stock is in Momentum
Stock is currently overvalued by the market with the expectation of annual earning growth at 211.2% to match current price.
Overvalued stock can be traded very volatile. If the earning growth momentum continue, overvalued stock can match into fair value, on the flip side, the downside risk can be huge if the stock is not meeting the market expectation.
Company is not in Profit
- UCREST current price is 870% above OneDelta estimated fair value.
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Relative Price Performance
OutperformedUCREST past 5-day return perform better than Telecommunications industry average return by 54.52%
Above 30-Day AverageCurrent price RM0.485 is above than 30-day average RM0.26 by 86.5%
Bank Analyst Price Targets
Revenue & Earning Growth Analysis
High Volatile Revenue Growth
UCREST experienced high unstable ups & downs on revenue growth for past 4 quarters with average 22% range on both sides.
Potential Better Profit Growth
UCREST posted a better profit growth than average in the recent quarter.
Past Quarter Reports
|Quarter Date||Revenue (RM)||(%)||EPS (RM)||(%)|
Volume Trend Analysis
Recent Volume is Increasing
Surge in trading volume tends to bring more price volatility in near term.
UCREST recent daily traded volume is 254.18% higher than past month average.
|Past 30-Day||Past 5-Day|
|1,292k daily||4,576k daily|
Price History Chart
Past 30-day Average Price: RM0.26
Stock Fundamental Factors
Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.
Stock Thematic Baskets
Usually the more the stock is included in popular themes, the more opportunity for price-driven momentum and better liquidity.
Market News & Investor Opinions
Stock Company Profile
UCrest Bhd. is an investment holding company, which engages in the design, development, and marketing of information technology products and services. Its services include i-Medic, and Genetic Tests. It operates through the following geographical segments: Malaysia, Singapore, and Russia. The company was founded by Kah Yee Eg in 1997 and is headquartered in Petaling Jaya, Malaysia.